Aphea.Bio - About the company
Aphea.Bio is a series C company based in Zwijnaarde (Belgium), founded in 2017 by Isabel Vercauteren. It operates as an Innovating biological solutions for sustainable agriculture through biocontrol and biostimulant products. Aphea.Bio has raised $109M in funding from investors like Innovation Industries, VLAIO and V-Bio Ventures. The company has 1682 active competitors, including 60 funded and 79 that have exited. Its top competitors include companies like Ginkgo Bioworks, Koppert and IPL Biologicals.
Company Details
Innovating biological solutions for sustainable agriculture through biocontrol and biostimulant products. The company develops natural solutions for agriculture, focusing on microbial-based products. It utilizes its APEXbio™ R&D platform to harness the diversity of microorganisms, creating a high-throughput pipeline for discovering new products. The firm is dedicated to driving the transition to a sustainable future through result-driven science and innovation. Its pipeline includes biostimulants, biofungicides, bioherbicides, and bioinsecticides. The company is committed to challenging conventional norms in agriculture by providing powerful and novel biological solutions.
- Website
- www.aphea.bio/
- Social
- Email ID
- *****@aphea.bio
- Phone Number
- +32 **********
- Registered Address
- Technologiepark-Zwijnaarde 21 9052 Ghent
Key Metrics
Founded Year
2017
Location
Zwijnaarde, Belgium
Stage
Series C
Total Funding
$109M in 6 rounds
Latest Funding Round
Investors
Ranked
59th among 1682 active competitors
Annual Revenue
€0 - €1M as on Dec 31, 2024
Employee Count
64 as on Sep 30, 2026
Similar Companies
Legal entities associated with Aphea.Bio
Aphea.Bio is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
Aphea.Bio CIN: 0666.961.607 , Belgium, Active | Dec 04, 2016 | €0 - €1M (As on Dec 31, 2024) | 40 (As on Dec 31, 2022) | - |
Sign up to download Aphea.Bio's company profile
Aphea.Bio's funding and investors
Aphea.Bio has raised a total funding of $109M over 6 rounds. Its first funding round was on Jun 16, 2017. Its latest funding round was a Series C round on Nov 04, 2024 for $*****. 1 investor participated in its latest round. Aphea.Bio has 18 institutional investors.
Here is the list of recent funding rounds of Aphea.Bio:
Filter this list
Filter this listDate of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Nov 04, 2024 | 8398828 | Series C | 5370743 | 6556707 | 8053131 | 1999396 |
Jul 11, 2023 | 9808203 | Series C | 1538044 | 3398829 | 3773543 | |
Apr 14, 2021 | 4255390 | Series B | 3806742 | 3078111 | 8434353 |
Access funding benchmarks and valuations. Sign up today!View details of Aphea.Bio's funding rounds and investors
Aphea.Bio's founders and board of directors
Founder? Claim ProfileThe founders of Aphea.Bio is Isabel Vercauteren. Isabel Vercauteren is the CEO of Aphea.Bio.
Here are the details of Aphea.Bio's key team members:
- Isabel Vercauteren: Co-Founder & CEO of Aphea.Bio. Contact Info: 1 email address and 1 phone number
View details of Aphea.Bio's Founder profiles and Board Members
Aphea.Bio's employee count trend
Aphea.Bio has 64 employees as of Sep 26. Here is Aphea.Bio's employee count trend over the years:
Uncover Aphea.Bio's growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Aphea.Bio's Competitors and alternates
Top competitors of Aphea.Bio include Ginkgo Bioworks, Koppert and IPL Biologicals. Here is the list of Top 10 competitors of Aphea.Bio, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Ginkgo Bioworks 2008, Boston (United States), Public | Autonomous labs for biotechnology, empowering scientists to design the living world | $796M | 81/100 | |
2nd |  Koppert 1967, Berkel en Rodenrijs (Netherlands), Late Stage | Provider of biological crop protection and pollination solutions for growers | $150M | 69/100 | |
3rd |  IPL Biologicals 1994, Gurugram (India), Series B | Manufactures and supplies plant nutrition & protection products | $17.6M | 66/100 | |
4th |  Corteva Agriscience 2018, Indianapolis (United States), Public | Manufacturer of crop protection products seeds and biological agricultural solutions | - | 59/100 | |
5th | Industrial Microbes 2014, Emeryville (United States), Seed | Manufacturer of biobased acrylic acid using engineered microbial fermentation processes | $10.1M | 59/100 | |
6th |  Pro Farm Group 2006, Davis (United States), Public | Developer of biological crop solutions and technology platforms for agriculture | $39.2M | 58/100 | |
7th | Pluton Biosciences 2017, St. Louis (United States), Series A | Provider of assay-based microbial research services | $24.2M | 57/100 | |
8th | Ceradis 2005, Wageningen (Netherlands), Acquired | Innovative crop protection and plant nutrition solutions for sustainable agriculture | $15.8M | 57/100 | |
9th |  Zymergen 2013, Emeryville (United States), Acquired | Platform utilizing genomics and machine learning to research and develop novel materials | $883M | 56/100 | |
10th | Manufacturer of biological solutions for agriculture feed and industrial applications | $11.2M | 55/100 | ||
59th | Innovating biological solutions for sustainable agriculture through biocontrol and biostimulant products | $109M | 41/100 |
_1579507702702.png?devicePixelRatio=2&height=30&width=30){kind=logo}
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Aphea.Bio's competitors? Click here to see the top ones
Aphea.Bio's Investments and acquisitions
Aphea.Bio has made no investments or acquisitions yet.
Reports related to Aphea.Bio
Here is the latest report on Aphea.Bio's sector:
News related to Aphea.Bio
Filter this list•
Aphea.Bio Secures €1.9M to Advance INITIΛ for Maize ExpansioniGrow News•Nov 05, 2024•Aphea.Bio, VLAIO
•
Aphea.Bio Welcomes Hadyn Parry as Chairman of its Board: Propelling the company's vision for Sustainable AgricultureAphea.Bio•Oct 01, 2024•Aphea.Bio
•
Aphea.Bio submits applications for first biofungicides VALORIA™ and VIRTUOSA™ for regulatory approval to the EPA (US)Aphea.Bio•Aug 05, 2024•Aphea.Bio
•
€ 1.9 million in VLAIO Funding Boosts Aphea.Bio’s Biostimulant INITIΛ by Aphea.Bio™Aphea.Bio•Apr 11, 2024•Aphea.Bio, VLAIO
•
Hartmut van Lengerich Appointed as Chairman of Aphea.Bio's Strategic Advisory BoardAphea.Bio•Jan 17, 2024•Aphea.Bio
•
•
Backed by the Bill & Melinda Gates Foundation and others, Belgian agtech firm Aphea.bio raises €70 millionTech.eu•Jul 12, 2023•Aphea.Bio, Innovation Industries, Gates, Korys and 8 others
•
Aphea.Bio secures € 70 million Series C Funding, accelerating the company's commercialisation effortsAphea.Bio•Jul 11, 2023•Aphea.Bio, Innovation Industries
•
Syngenta and Aphea.Bio collaborate to bring novel wheat biostimulant to European marketsAgroPages•Mar 09, 2023•Syngenta, Aphea.Bio
•
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about Aphea.Bio
Explore our recently published companies
- Stipendium - Switzerland based, Unfunded company
- Sonvisage - Unfunded company
- Swiss Alpine Herbs - SAH Alpenkrauter - Switzerland based, 1991 founded, Unfunded company
- Miconvey - Chongqing based, 2013 founded, Unfunded company
- Marc's Work - 1970 founded, Unfunded company
- KEY68 - Fremont based, Unfunded company
